Ni-Na Tsao

Title: Ni-Na Tsao: Innovator in Recombinant Protein Technology

Introduction

Ni-Na Tsao is a notable inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of recombinant protein technology, holding 2 patents that focus on innovative methods for treating infections.

Latest Patents

One of his latest patents is the FSBM recombinant protein, which is designed to confer protection against group C infection in animal subjects. This invention comprises four peptide fragments, each with specific amino acid sequences that are crucial for its function. The patent also outlines a method for protecting an animal subject against group C infection, showcasing the potential applications of this recombinant protein in veterinary medicine.

Another significant patent involves a method for treating infections caused by group A Streptococcus (GAS). This method includes identifying patients as invasive infected candidates based on specific criteria and administering antibiotics accordingly. The innovative approach aims to enhance treatment efficacy for patients suffering from GAS infections.

Career Highlights

Ni-Na Tsao is affiliated with I-Shou University, where he continues to engage in research and development in the field of biotechnology. His work not only contributes to academic knowledge but also has practical implications for medical treatments.

Collaborations

He collaborates with esteemed colleagues, including Chih-Feng Kuo and Ching-Chuan Liu, who contribute to his research endeavors. Their combined expertise enhances the quality and impact of their work in the field.

Conclusion

Ni-Na Tsao's innovative work in recombinant protein technology exemplifies the potential of scientific research to address pressing health challenges. His patents reflect a commitment to advancing medical treatments and improving patient outcomes.